ARDX ARDELYX, INC.

ARDX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1437402 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations)
Showing 3 of 14 annual and 0 of 52 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$923.71M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Incorporated
DE
Fiscal Year End
December (1231)
Phone
510-745-7047
EIN
000000000
Headquarters
FREMONT, CA, 94555
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: NTERYX INC (2008–2008)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$450.89M
Net Income
$-55.70M
Total Assets
$575.89M
Total Equity
$149.01M
Total Debt
-
Free Cash Flow
$-17.92M
Ratios
Gross Margin
94.4%
Operating Margin
-7.9%
Net Margin
-12.4%
Return on Equity
-37.4%
Return on Assets
-9.7%
Current Ratio
3.34x
FCF / Assets
-3.1%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, ARDELYX, INC. recorded $407.32M of revenue, net loss of $61.60M, and an operating cash outflow of $42.48M. Revenue of $407.32M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 22.1% above fiscal 2024 revenue of $333.62M, marking a year-over-year increase. The company reported diluted EPS of -$0.26, adding a shareholder-level measure to the absolute income figures considered below. The company employed $501.60M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Asset turnover was 0.81x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

The first profit layer was $367.78M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 90.3% of revenue, showing how much of the top line remained after direct costs. The company recorded an operating loss of $40.98M after the reported operating expense base. Relative to revenue, the operating deficit measured 10.1%, showing the shortfall after operating costs. After all below-operating-line items, the company recorded a net loss of $61.60M for the fiscal year. Measured against revenue, the bottom-line deficit represented 15.1% after all recognized items. The company reported a pretax loss of $60.63M, before the effect of income taxes. Pretax margin was -14.9%, reflecting a pre-tax loss equal to 14.9% of revenue. The reported income-tax provision was $969.00K, the amount recognized between pretax income and the final net-income result. Relative to period-end equity, the net loss represented 36.9%. Relative to total assets, the net loss represented 12.3%. Compared with a $39.14M net loss in fiscal 2024, the current loss increased to $61.60M.

Liquidity and Capital Structure

Total assets were $501.60M, supported by $334.65M of liabilities and $166.95M of shareholder equity. The near-term balance sheet paired $382.32M of current assets with $88.61M of current liabilities at the reporting date. The current ratio was 4.31x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Reported cash and equivalents were $68.00M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 76.7% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Total debt was $202.83M, establishing the amount of borrowing carried within the company’s capital structure. The debt-to-equity relationship was 1.21x, showing how much debt the company carried for each unit of book equity. The debt-to-assets relationship was 40.4%, comparing borrowing with the total asset balance. The liabilities-to-assets relationship was 66.7%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 13.6%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $435.75M in fiscal 2024, the current asset base moved 15.1% and finished higher. Book equity was 3.7% lower than fiscal 2024 equity of $173.29M, showing how shareholder capital changed year over year. Cash and equivalents were 4.7% higher than fiscal 2024 cash of $64.93M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

Operating activities used $42.48M of cash, resulting in an operating cash outflow for the year. Capital spending of $1.49M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Negative free cash flow was $43.98M, leaving a cash deficit after capital spending and reducing financial flexibility. Free-cash-flow margin was -10.8%, reflecting a cash deficit equal to 10.8% of revenue after capital spending. Relative to total assets, the post-investment cash deficit measured 8.8%.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for ARDELYX, INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $407.32M $333.62M $124.46M
Cost of Revenue $39.54M $50.56M $17.80M
Gross Profit $367.78M $283.06M $106.66M
OPERATING EXPENSES
R&D Expense $71.53M $52.32M $35.54M
SG&A Expense $337.23M $258.69M $134.40M
Other Operating Expenses (derived) $0 $0 $0
Operating Income $-40.98M $-27.95M $-63.28M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $4.95M
Other Income/Expense $8.75M $9.17M $6.63M
Pretax Income $-60.63M $-38.87M $-65.52M
Income Tax $969.00K $266.00K $547.00K
Net Income $-61.60M $-39.14M $-66.07M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.26 $-0.17 $-0.30
Diluted Shares 241.03M 235.23M 219.33M
EBITDA $-37.92M $-25.89M $-61.98M
Depreciation & Amortization $3.06M $2.06M $1.29M
Balance Sheet
ASSETS
Cash & Equivalents $68.00M $64.93M $21.47M
Short-term Investments $196.69M $185.17M $162.83M
Accounts Receivable $71.85M $57.71M $22.03M
Inventory $123.11M $91.18M $49.49M
Other Current Assets $13.57M $11.10M $8.41M
Current Assets $382.32M $356.45M $246.11M
PP&E (Net) $2.18M $1.50M $1.01M
Other Noncurrent Assets $6.94M $5.42M $3.60M
Noncurrent Assets $119.29M $79.30M $51.47M
Total Assets $501.60M $435.75M $297.58M
LIABILITIES
Accounts Payable $19.24M $16.00M $11.14M
Other Current Liabilities $7.35M $6.54M $4.88M
Current Liabilities $88.61M $77.83M $50.39M
Long-term Debt $202.83M $150.85M $49.82M
Other Noncurrent Liabilities (derived) $43.22M $33.78M $30.55M
Noncurrent Liabilities $246.05M $184.64M $80.37M
Total Liabilities $334.66M $262.47M $130.76M
EQUITY
Common Stock $24.00K $24.00K $23.00K
Additional Paid-in Capital $1.11B $1.06B $1.01B
Retained Earnings $-946.94M $-885.34M $-846.20M
Accumulated OCI $198.00K $57.00K $224.00K
Total Equity $166.95M $173.29M $166.82M
Total Liabilities & Equity $501.60M $435.75M $297.58M
SUPPLEMENTAL
Shares Outstanding 244.35M 238.02M 232.45M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $-42.48M $-44.81M $-89.72M
Capital Expenditures $1.49M $1.01M $344.00K
Cash from Investing $-8.96M $-18.32M $-131.25M
Cash from Financing $54.51M $106.59M $146.30M
Free Cash Flow $-43.98M $-45.82M $-90.06M
Beginning Cash (CFS) $64.93M $21.47M -
Net Change in Cash $3.07M $43.46M -
Effect of FX on Cash - - -
Calculated Ending Cash $68.00M $64.93M -
Cash per BS $68.00M $64.93M $21.47M
Cash scope difference (CFS − BS) - - -
Cash per CFS $68.00M $64.93M $21.47M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ARDELYX, INC.'s annual revenue?

ARDELYX, INC. reported $450.89M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ARDELYX, INC. profitable?

No. ARDELYX, INC. reported $-55.70M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does ARDELYX, INC. generate free cash flow?

No. Free cash flow was $-17.92M for trailing twelve months. Operating cash flow was $-17.32M.